Karas Eric
- SEC CIK
- 0001951287
In the past year, 1 open-market sale filing worth $250.0K and no purchases.
Current role at each company
- SPRY ARS Pharmaceuticals, Inc.Chief Commercial Officeras of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $250.0K
- 1 filing
- Net
- −$250.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Karas Eric as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 (view filing) | Jun 12 | Same day | Karas EricChief Commercial Officer | SSale | −25.0K | $10.00 | −$250.0K | −67.2%12.2K after | 10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Karas EricChief Commercial Officer | SSale | −15.0K | $16.99 | −$254.8K | −59.3%10.3K after | 10b5-1 |
| Jun 20, 2025 (view filing) | Jun 18 | 2 days | Karas EricChief Commercial Officer | SSale | −15.0K | $16.00 | −$240.0K | −66.1%7.70K after | 10b5-1 |
| Mar 21, 2025 (view filing) | Mar 20 | 1 day | Karas EricChief Commercial Officer | SSale | −10.0K | $14.00 | −$140.0K | −56.5%7.70K after | 10b5-1 |
| Dec 4, 2024 (view filing) | Dec 2-4 | 2 days | Karas EricChief Commercial Officer | SSale | −10.0K | $14.04 | −$140.4K | −63.7%5.69K after | 2 lots10b5-1 |
| Sep 19, 2024 (view filing) | Sep 18 | 1 day | Karas EricChief Commercial Officer | SSale | −10.0K | $14.00 | −$140.0K | −63.7%5.69K after | 10b5-1 |
| Aug 21, 2024 (view filing) | Aug 19 | 2 days | Karas EricChief Commercial Officer | SSale | −10.0K | $14.00 | −$140.0K | −63.7%5.69K after | 10b5-1 |